PDCD1 and neoplasm: Targeting mitochondria can likely block the mitochondria’ migration through the nanotubes, thereby shifting the energy balance toward the tumor-fighting immune cells (see Section 3.1), which can improve the response to anti-programmed cell death protein-1 (PD-1) agents [46].